1. Introduction {#sec1}
===============

Hypotrichosis is a type of hair loss and commonly begins in early childhood.[@bib1] In hypotrichosis, sparse hair is the result of impaired regeneration, caused by defects in hair cycling and anchoring of the hair shaft in the skin.[@bib1], [@bib2] Mutations in different genes have been associated with non-syndromic forms of hypotrichosis.[@bib3] However, hypotrichosis can also be a component of a syndrome. Hypotrichosis with juvenile macular dystrophy (HJMD; MIM601553) is among the typical forms of these disorders.[@bib2], [@bib4] This autosomal-recessive disorder is caused by mutations in the *CDH3* gene, which encodes P-cadherin and is responsible for calcium-dependent cell-to-cell adhesion.[@bib4] The gene is expressed in retinal pigment epithelium (RPE) and the hair matrix at various stages of development of these tissues.[@bib2], [@bib4]

Hypotrichosis is very rare and has been described mostly in Arab Muslim, Israeli, Turkish, and Pakistani families who reside in middle and near east countries.[@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18] Its prevalence is unknown and has only been reported in approximately 30 patients since the first case was described in 1935 by Wagner.[@bib1] It is characterized by sparse hair and progressive degeneration of the central retina, leading to legal blindness during the first 30 years of life.[@bib4]

Here, we present the clinical characteristics of a case with HJMD associated with a novel *CDH3* gene mutation in a non-consanguineous Turkish family. We also summarize the results of molecular analyses of 20 previously described HJMD families and discuss the detailed phenotypic presentation and genotype-phenotype correlation of patients tested molecularly.

1.1. Case report {#sec1.1}
----------------

A 13-year-old girl with a clinical diagnosis of congenital hypotrichosis was referred to us with bilateral progressive visual deterioration. The visual symptoms commenced when she was 8 years old. Her parents, of Turkish origin, were not consanguineous and she had a healthy brother. Neither her parents nor the brother had hypotrichosis or any visual complaint. On physical examination, she had short, straight sparse and slow growing hair without erythema or scales ([Fig. 1](#fig1){ref-type="fig"}a and b). Hair pull test results and scalp skin texture were normal. The eyebrows and eyelashes were normal. No associated abnormality in her teeth, nails, or limbs was noted. Otherwise, her skin was normal. Complete blood count and ferritin, iron, transferrin, vitamin B12, and thyroid hormone levels were within normal ranges. On eye examination, eye movements and pupillary reflexes were normal and no afferent pupillary defect was present. Best-corrected visual acuity was 9/10 in OD and 1/10 in OS. Cycloplegic refraction was +0.50 diopters OU. Axial eye length was measured with an IOL Master (ver. 3.02; Carl Zeiss, Meditec, Jena, Germany) as 23.49 mm in OD and 24.25 mm in OS. Slit-lamp examination was unremarkable OU. Intraocular pressure was 16 mmHg bilaterally. Fundus examination revealed ring-shaped atrophy of the RPE with patchy intraretinal pigment clumping at the posterior pole bilaterally. However, foveola seemed to be relatively preserved in OD. Atrophy of the RPE and choriocapillaris involved the foveal region of the left eye. The affected posterior pole and healthy looking equatorial retina were well-demarcated bilaterally ([Fig. 1](#fig1){ref-type="fig"}c and d). Autofluorescence imaging showed a symmetrical wedge-shaped hypoautofluorescent area, corresponding to the RPE atrophy, which was surrounded by a hyperautofluorescent rim ([Fig. 1](#fig1){ref-type="fig"}e and f). Optical coherence tomography (OCT) demonstrated disruption of the photoreceptor and inner segment/outer segment junction, retinal thinning in OU, and a posterior staphyloma-like appearance in OS ([Fig. 1](#fig1){ref-type="fig"}g and h). Electrophysiological tests were performed using a MetroVision system (MetroVision, Perenchies, France). The electrooculogram (EOG) was within normal limits in OD but subnormal in OS. The rod electroretinogram (ERG) was considered subnormal OU. The standard-combined ERG, cone ERG, and flicker ERG were within normal limits OU ([Fig. 2](#fig2){ref-type="fig"}).Fig. 1**a**, **b** Hypotrichosis associated with sparse and short hair. **c**, **d** Color fundus picture of the OD **c** and OS **d** indicating the central ring-shaped retinal pigment epithelium (RPE) atrophy and clearly demarcated healthy retina and affected posterior pole, and **e**, **f** showing the symmetrical wedge-shaped hypoautofluorescent area surrounded by a hyperautofluorescent rim. **g**, **h** Optical coherence tomography appearance. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 1Fig. 2Electrophysiological tests.Fig. 2

1.2. Genotyping and mutation analysis {#sec1.2}
-------------------------------------

Genomic DNA was isolated from a peripheral blood sample using a salting-out method. All of the coding region, along with flanking intron regions, of the *CDH3* gene was amplified by polymerase chain reaction (PCR; primer sequences are available on request). For sequencing, the PCR products were purified using the ExoSAP-IT (GE Healthcare Bio-Sciences, Piscataway, NJ, USA), following the manufacturer\'s protocol. Sequence reactions were run on an ABI Prism 3130*xl* DNA Sequencer and analyzed with the supplied sequencing analysis software (ver. 5.4; Applied Biosystems, Foster City, CA, USA). DNA sequencing analysis detected a novel homozygous deletion (c.447_467del (p.149_156del)) in exon 5 of the patient. This non-frameshift deletion was predicted as disease-causing by MutationTaster. Both healthy parents and the older brother were heterozygous for the mutation, consistent with an autosomal-recessive mode of inheritance. This mutation has not been reported before in HJMD syndrome.

2. Discussion {#sec2}
=============

Sprecher et al.[@bib4] showed the first mutation in the *CDH3* gene causing HJMD in a Druze-origin family. A few years later, Kjaer et al.[@bib5] reported that mutations in the *CDH3* gene also caused ectodermal dysplasia, ectrodactyly, and macular dystrophy (EEM syndrome; OMIM [225280](225280){#intref0010}). These two overlapping syndromes have common features, such as hypotrichosis and macular dystrophy. It was thought that EEM syndrome differed from HJMD by the presence of limb anomalies. However, recent reports and genetic analyses showed that limb anomalies may be present in both syndromes.[@bib6] Basel-Vanagaite et al.[@bib2] suggested that these syndromes represented a continuous phenotypic spectrum related to mutations in the *CDH3* gene and classified them as *CDH3*-related syndromes, rather than different genetic syndromes.

Moreover, patients with same genotype in *CDH3*-related syndromes may have different clinical manifestations. The same mutation (c.829del: p. G277fs) in exon 7 was found in a Turkish HJMD family and a Brazilian EEM family in two separate studies by Indelman[@bib6] and Kjaer et al.[@bib5] Hair anomalies and retinal pigmentary alterations were present in both families but limb defects were observed only in the EEM family. Thus, Kjaer et al.[@bib5] suggested that HJMD and EEM represented phenotypic heterogeneity within the same syndrome. This considerable phenotypic variation for the same mutation may also point toward other genetic factors.

The *CDH3* gene consists of 16 exons, spanning ∼55 kilobases of genomic DNA, and is localized on the long arm of chromosome 16. The *CDH3* protein is a member of the P-cadherin protein family and conforms to the general structure of the 'classic' cadherins, a group of molecules expressed in a tissue-specific manner that form a major part of adherence junctions in most epithelial tissues. Classical cadherins are composed of five extracellular domains (ECs), one transmembranal domain (TM), and one intracytoplasmic domain (IC)[@bib2], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15] The first extracellular domain (EC1), encoded by the DNA sequences of exons 4 and 5, is important for hemophilic adhesion and contains conserved tryptophan residues that are responsible for trans-cadherin binding. To date, 20 mutations -- 7 deletions,[@bib4], [@bib7], [@bib10], [@bib17], [@bib18] 4 missense,[@bib7], [@bib9], [@bib10], [@bib12] 4 splice-site,[@bib13], [@bib14], [@bib15] 3 nonsense,[@bib11], [@bib16], [@bib18] and 2 compound heterozygous[@bib6] -- have been reported in the *CDH3* gene in patients with HJMD. [Table 1](#tbl1){ref-type="table"} summarizes the reported *CDH3* gene mutations in HJMD. In the present study, we have identified a novel homozygous for a non-frameshift deletion mutation (c.447_467del (p.149_156del)) in exon 5, which affects the EC1 of P-cadherin. This mutation is predicted to result in a markedly altered structure and function of P-cadherin, which likely disrupts the mechanism of cell-cell adhesion.Table 1*CDH3* mutations and clinical features in previously reported patients with hypotrichosis with juvenile macular dystrophy.Table 1ReferencesOriginVisual acuity (OD/OS)Skalp hypotrichosisMacular pigment degenerationAdditional clinical findingsCDH3 mutation typesSprecher et al.,[@bib4] 2001IsraeliNR++NRc.981del (p.M327fs)Homozygous frameshift deletionIndelman et al.,[@bib6], [@bib9], [@bib10], [@bib11] 2002IsraeliNR++NRc.1508G \> A (p.R503H)Homozygous missense2003FrenchNR++Atopic dermatitisc.503T \> A (p.L168X) c.2112del (p.G706fs)Heterozygous Stopgain and heterozygous frameshift deletion2003TurkishNR++Keratosis pilarisc.829del (p.G277fs)Homozygous frameshift deletion2003IsraeliNR++Centrofacial lentiginosisc.1508G \> A (p.R503H)Homozygous missense2003IsraeliNR++NRc.462del (p.E155fs)Homozygous frameshift deletion2005ArabOD:20/28, OS: 20/33++NRc.1845T \> G (p.Y615X)Homozygous Stopgain2007EnglishOD: 6/36, OS: 6/5++Limb abnormalitiesc. IVS2+1G \> A c.1510G \> A (p.E504K)Heterozygous Splice site and Heterozygous missense2007AmericanNR++Discolored primary teeth, nail dystrophyc.661C \> T (p.R221X) c.1724A \> G (p.H575R)heterozygous Stopgain and heterozygous frameshift deletionBergman et al.,[@bib12] 2004Arab-IsraeliNR+NRCentrofacial lentiginosisc.1508G \> A (p.R503H)Homozygous missenseLiebu et al.,[@bib7] 2006IsraeliNR++NRc.981del (p.M327fs)Homozygous frameshift deletion2006IsraeliNR++NRc.1508G \> A (p.R503H)Homozygous missenseJelani et al.,[@bib13] 2009PakistaniNR++NRc.IVS10-1G \> THomozygous Splice siteHassan et al.,[@bib14] 2010PakistaniNR++NRc.IVS10-1G \> AHomozygous Splice siteShimomura et al.,[@bib15] 2010PakistaniNR+NRNRc.IVS12-2A \> GHomozygous Splice site2010PakistaniNR+NRNRc.IVS10-1G \> THomozygous Splice siteAvitan-Hersh.,[@bib16] 2012ArabNR++NRc.747C \> A (p.Y249X)Homozygous StopgainHalford et al.,[@bib17] 2012NROD: 6/760, OS: 6/96++NRGross Deletion 8815bp including exons 12--13Homozygous deletionKhan et al.,[@bib18] 2016ArabOD: 20/60, OS: 20/60++Slow nail growthc.307C \> T (p.R103X)Homozygous Stopgain2016ArabOD: 3/200, OS: 3/200++NRc.307C \> T (p.R103X)Homozygous StopgainPresent studyTurkishOD: 0.9, OS: 0.1++--c.447_467del (p.149_156del)Homozygous nonframeshift deletion[^1]

In a typical HJMD family, family members may have different phenotypes and present with various hair morphologies, skin changes, and eye involvement[@bib10] Furthermore, Indelman et al.[@bib10] reported significant inter- and intra-familial discrepancies in a series of families of various ethnic origins. In their study, even among members of the same family, the hair, skin, and retinal phenotypes varied widely. They reported an intriguing case of intra-familial phenotypic heterogeneity where two of three affected individuals in a family displayed centrofacial lentiginosis. They also reported three affected girls, aged 9, 11, and 13 years, in a family where the parents were healthy and of white, northern American descent. Only the eldest child had discolored primary teeth and nail dystrophy. In light of their observation, they suggested that variation in the phenotype was not correlated with the genotype.

Generally, HJMD patients have similar fundus changes, including ring-like retino-choroidal atrophy with patchy intraretinal pigment clumping at the posterior pole bilaterally.[@bib4], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib13], [@bib14], [@bib16], [@bib17], [@bib18] However, Mason et al.[@bib8] described a HJMD patient with bull\'s eye maculopathy. Liebu et al.[@bib7] also pointed out that some patients with HJMD might have different fundus appearances, such as diffuse hypopigmentation associated with coarse granular pigmentation and white-yellowish flecks in the macular area and beyond. They demonstrated that the type and extent of fundus abnormality might vary between patients with different disease entities despite having the same genetic mutation. A macular hole was described by Khan et al.[@bib18] In HJMD patients, no phenotype-genotype correlation has been established for hair and retinal changes between the type of mutation and its location along the *CDH3* gene. These studies suggest that the allelic mutation may not be the only factor that determines the clinical status. Given this complex genotype-phenotype correlation of *CDH3* mutations, more research is required.

In all previous reports on patients with HJMD, reduced visual acuity was the presenting ocular symptom, as in our case. Visual deterioration commences in the first decade of life[@bib6], [@bib7], [@bib11], [@bib18] However, Halford et al.[@bib17] described two patients who experienced visual loss at the age of 17 years. The extent of vision loss varies, and is difficult to predict. Visual acuity usually declines to 10/32 or worse.[@bib17], [@bib18] In the present case, the visual symptoms commenced when our female patient was 8 years old and worsened over the next 2 years. At an age of 10 years, her visual acuity was 10/10 in the right and 2/10 in the left eye. However, at her most recent visit, the visual acuity was 9/10 in the right and 1/10 in the left eye. Disruption of the photoreceptor-inner/outer segment junction was more prominent in the left than the right eye. The left eye also exhibited a posterior staphyloma-like appearance. Therefore, the visual loss was more severe. Many studies have included visual acuity data; the losses were usually symmetrical.[@bib11], [@bib17], [@bib18] However, asymmetric involvement was reported by Indelman et al.[@bib6] The visual acuity was 6/36 in the right and 6/5 in the left eye of one patient. The extent of asymmetry in our case was similar.

3. Conclusions {#sec3}
==============

We describe a novel homozygous mutation (c.447_467del (p.149_156del)) in the *CDH3* gene in a non-consanguineous Turkish family. No significant phenotypic difference was observed between our case and previously described patients with *CDH3* mutations from different parts of the world. As HJMD is a rare clinical entity, pediatricians, dermatologists, and ophthalmologists in particular should be aware of the clinical spectrum of this disease. Sparse hair in childhood, with or without limb anomalies, should alert clinicians to request an ophthalmological evaluation to assess possible retinal abnormalities.
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[^1]: Abbreviation: NR, not reported.
